©The Author(s) 2026.
World J Gastrointest Surg. Jan 27, 2026; 18(1): 114262
Published online Jan 27, 2026. doi: 10.4240/wjgs.v18.i1.114262
Published online Jan 27, 2026. doi: 10.4240/wjgs.v18.i1.114262
Table 4 Short-term and long-term results
| Before propensity score matching | After propensity score matching | |||||
| Open group, | Laparoscopic group, | P value | Open group, | Laparoscopic group, | P value | |
| Short-term outcome | ||||||
| Length of stay (day) | 27 ± 17 | 17 ± 14 | 0.010 | 24 ± 10 | 19 ± 16 | 0.260 |
| Ascites (C-D I or II) | 13 (18.3) | 0 (0) | 0.019 | 4 (21.1) | 0 (0) | 0.035 |
| Ascites (C-D III or IV) | 3 (4.2) | 0 (0) | 0.290 | 0 (0) | 0 (0) | NA |
| Bile leakage (C-D III or IV) | 6 (8.5) | 1 (3.9) | 0.440 | 1 (5.3) | 1 (5.3) | 1.000 |
| Liver failure (C-D III or IV) | 9 (12.7) | 3 (11.5) | 0.880 | 2 (10.5) | 2 (10.5) | 1.000 |
| All morbidity (C-D III or IV) | 14 (19.7) | 3 (11.5) | 0.350 | 3 (15.8) | 2 (10.5) | 0.630 |
| Mortality at 30 days | 0 (0) | 0 (0) | NA | 0 (0) | 0 (0) | NA |
| Mortality at 90 days | 3 (4.2) | 0 (0) | 0.290 | 0 (0) | 0 (0) | NA |
| Long-term outcome | ||||||
| Recurrence | 47 (66.2) | 14 (53.9) | 0.260 | 11 (57.9) | 9 (47.4) | 0.520 |
| Death | 38 (53.5) | 4 (15.4) | 0.001 | 10 (52.6) | 2 (10.5) | 0.005 |
| Cancer | 27 (38.0) | 4 (15.4) | 0.018 | 7 (36.8) | 2 (10.5) | 0.080 |
| Liver failure due to cirrhosis | 5 (7.0) | 0 (0) | 0.160 | 1 (5.3) | 0 (0) | 0.310 |
| Infection | 4 (5.6) | 0 (0) | 0.220 | 1 (5.3) | 0 (0) | 0.310 |
| Other cancer | 2 (2.8) | 0 (0) | 0.390 | 1 (5.3) | 0 (0) | 0.310 |
- Citation: Kijpongpans K, Ariizumi S, Ome Y, Kawamoto Y, Matsunaga Y, Honda G. Laparoscopic hepatectomy is feasible for patients diagnosed with hepatocellular carcinoma and cirrhotic liver. World J Gastrointest Surg 2026; 18(1): 114262
- URL: https://www.wjgnet.com/1948-9366/full/v18/i1/114262.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v18.i1.114262